August 4, 2014 by Arezu Sarvestani
Leadership at Johnson & Johnson and Teleflex weigh in on the multi-billion-dollar mergers that are shifting the landscape of the medical device industry.
MASSDEVICE ON CALL — More medical device giants offered their 2¢ on high-dollar mega-mergers, joining other companies in saying that they aren’t planning any billion-dollar buys just yet.
Johnson & Johnson (NYSE:JNJ) CEO Alex Gorsky said in an interview with Beaker’s Blog that he wasn’t surprised to see device makers engaging in multi-billion dollar mergers, and that J&J had taken steps years before to beat the trend.
“We definitely saw consolidation in the future simply because of the number of different participants you had in the market,” Gorsky told Beaker’s. J&J began talks in 2011 to acquire Synthes, a deal that closed for $19.7 billion that June.
